PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, Barcelona, Spain.\', \'School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.\', \'Centro de Investigación Biomédica en Red (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.\', \'CRIPS, Vall d\'Hebrón Institute of Research, Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/phar.2627
?:doi
?:hasPublicationType
?:journal
  • Pharmacotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34558742
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.28
?:rankingScore_hIndex
  • 97
is ?:relation_isRelatedTo_publication of
?:title
  • Beneficial and harmful outcomes of tocilizumab in severe COVID-19: A systematic review and meta-analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34558742>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34558742>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all